Charles River Laboratories International (CRL) Competitors

$233.47

+11.66 (+5.26%)

(As of 07/26/2024 ET)

CRL vs. A, MTD, ILMN, WAT, TECH, BRKR, BIO, PACB, HBIO, and TMO

Should you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Agilent Technologies (A), Mettler-Toledo International (MTD), Illumina (ILMN), Waters (WAT), Bio-Techne (TECH), Bruker (BRKR), Bio-Rad Laboratories (BIO), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.

Charles River Laboratories International vs.

Agilent Technologies (NYSE:A) and Charles River Laboratories International (NYSE:CRL) are both large-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, community ranking, risk, valuation, dividends and media sentiment.

: Agilent Technologies has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Agilent Technologies $6.83B 5.86 $1.24B $4.23 32.46
Charles River Laboratories International $4.13B 2.91 $474.62M $8.50 27.47
: Agilent Technologies received 371 more outperform votes than Charles River Laboratories International when rated by MarketBeat users. Likewise, 71.49% of users gave Agilent Technologies an outperform vote while only 61.34% of users gave Charles River Laboratories International an outperform vote.
Company Underperform Outperform
Agilent Technologies Outperform Votes
855
71.49%
Underperform Votes
341
28.51%
Charles River Laboratories International Outperform Votes
484
61.34%
Underperform Votes
305
38.66%
: Agilent Technologies has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500.
: Agilent Technologies has a net margin of 18.84% compared to Agilent Technologies' net margin of 10.81%. Charles River Laboratories International's return on equity of 26.25% beat Agilent Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Agilent Technologies 18.84% 26.25% 14.45%
Charles River Laboratories International 10.81% 15.16% 6.60%
: 98.9% of Charles River Laboratories International shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
: In the previous week, Agilent Technologies had 12 more articles in the media than Charles River Laboratories International. MarketBeat recorded 20 mentions for Agilent Technologies and 8 mentions for Charles River Laboratories International. Agilent Technologies' average media sentiment score of 1.06 beat Charles River Laboratories International's score of 0.56 indicating that Charles River Laboratories International is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilent Technologies
10 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Charles River Laboratories International
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: Agilent Technologies presently has a consensus target price of $138.06, suggesting a potential upside of 0.55%. Charles River Laboratories International has a consensus target price of $252.29, suggesting a potential upside of 8.06%. Given Agilent Technologies' higher possible upside, analysts plainly believe Charles River Laboratories International is more favorable than Agilent Technologies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilent Technologies
1 Sell rating(s)
6 Hold rating(s)

9 Buy rating(s)

0 Strong Buy rating(s)
2.50
Charles River Laboratories International
0 Sell rating(s)

7 Hold rating(s)

7 Buy rating(s)

0 Strong Buy rating(s)
2.50

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.83B	5.86	$1.24B	$4.23	32.46
Charles River Laboratories International	$4.13B	2.91	$474.62M	$8.50	27.47

Company	Underperform	Outperform
Agilent Technologies	Outperform Votes 855 71.49%	Underperform Votes 341 28.51%
Charles River Laboratories International	Outperform Votes 484 61.34%	Underperform Votes 305 38.66%

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	18.84%	26.25%	14.45%
Charles River Laboratories International	10.81%	15.16%	6.60%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	10 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Charles River Laboratories International	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	1 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50
Charles River Laboratories International	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Agilent Technologies beats Charles River Laboratories International on 11 of the 17 factors compared between the two stocks.

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Get Charles River Laboratories International News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRL vs. The Competition

Export to Excel

Metric	Charles River Laboratories International	Commercial physical research Industry	Medical Sector	NYSE Exchange
Market Cap	$12.03B	$5.60B	$5.29B	$18.49B
Dividend Yield	N/A	1.31%	2.72%	3.50%
P/E Ratio	27.47	22.45	155.18	25.42
Price / Sales	2.91	66.61	2,087.66	15.36
Price / Cash	13.23	25.78	35.71	19.61
Price / Book	3.33	3.64	4.94	5.08
Net Income	$474.62M	$139.94M	$111.73M	$977.27M
7 Day Performance	6.98%	2.48%	2.74%	1.51%
1 Month Performance	12.89%	7.31%	11.41%	6.13%
1 Year Performance	9.64%	-16.26%	10.02%	7.84%

Charles River Laboratories International Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
A Agilent Technologies	4.6006 of 5 stars 4.60 / 5 stars	$134.22 +2.7%	$138.06 +2.9%	+6.0%	$39.16B	$6.83B	31.73	18,100	Short Interest ↓ News Coverage
MTD Mettler-Toledo International	4.3291 of 5 stars 4.33 / 5 stars	$1,384.56 +1.7%	$1,301.25 -6.0%	+7.4%	$29.57B	$3.79B	38.83	17,300	Upcoming Earnings Short Interest ↓ Analyst Revision News Coverage
ILMN Illumina	4.8681 of 5 stars 4.87 / 5 stars	$115.92 -0.3%	$158.57 +36.8%	-38.1%	$18.47B	$4.50B	-14.22	9,300	Positive News
WAT Waters	4.3869 of 5 stars 4.39 / 5 stars	$305.50 +1.6%	$301.20 -1.4%	+8.3%	$18.12B	$2.96B	29.98	7,900	Upcoming Earnings News Coverage
TECH Bio-Techne	4.586 of 5 stars 4.59 / 5 stars	$77.61 +1.4%	$81.00 +4.4%	-8.7%	$12.23B	$1.14B	61.60	3,050	Short Interest ↓
BRKR Bruker	4.9747 of 5 stars 4.97 / 5 stars	$64.08 +3.1%	$81.78 +27.6%	-10.7%	$9.31B	$2.96B	23.30	9,707	Upcoming Earnings Short Interest ↓
BIO Bio-Rad Laboratories	4.3456 of 5 stars 4.35 / 5 stars	$309.91 +1.5%	$436.67 +40.9%	-25.0%	$8.84B	$2.67B	-29.91	8,030	Upcoming Earnings Short Interest ↑
PACB Pacific Biosciences of California	1.2717 of 5 stars 1.27 / 5 stars	$1.97 +4.8%	$6.38 +223.6%	-85.2%	$536.55M	$200.52M	-1.73	796	Gap Up
HBIO Harvard Bioscience	2.2123 of 5 stars 2.21 / 5 stars	$3.25 -1.5%	N/A	-30.8%	$141.15M	$112.25M	-16.25	490	Short Interest ↓ Gap Up
TMO Thermo Fisher Scientific	4.8507 of 5 stars 4.85 / 5 stars	$571.00 -0.6%	$605.63 +6.1%	+4.1%	$217.96B	$42.86B	36.63	122,000	Earnings Report Analyst Forecast Analyst Revision News Coverage